Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy

Nitric oxide (NO) is a key molecule in cardiovascular homeostasis and its abnormal delivery is highly associated with the occurrence and development of cardiovascular disease (CVD). The assessment and manipulation of NO delivery is crucial to the diagnosis and therapy of CVD, such as endothelial dys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tianxiang Ma, Zhexi Zhang, Yu Chen, Haoran Su, Xiaoyan Deng, Xiao Liu, Yubo Fan
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/d2c6afe4f2734a579c3cb8c8696edcc0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d2c6afe4f2734a579c3cb8c8696edcc0
record_format dspace
spelling oai:doaj.org-article:d2c6afe4f2734a579c3cb8c8696edcc02021-11-25T17:53:59ZDelivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy10.3390/ijms2222121661422-00671661-6596https://doaj.org/article/d2c6afe4f2734a579c3cb8c8696edcc02021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12166https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Nitric oxide (NO) is a key molecule in cardiovascular homeostasis and its abnormal delivery is highly associated with the occurrence and development of cardiovascular disease (CVD). The assessment and manipulation of NO delivery is crucial to the diagnosis and therapy of CVD, such as endothelial dysfunction, atherosclerotic progression, pulmonary hypertension, and cardiovascular manifestations of coronavirus (COVID-19). However, due to the low concentration and fast reaction characteristics of NO in the cardiovascular system, clinical applications centered on NO delivery are challenging. In this tutorial review, we first summarized the methods to estimate the in vivo NO delivery process, based on computational modeling and flow-mediated dilation, to assess endothelial function and vulnerability of atherosclerotic plaque. Then, emerging bioimaging technologies that have the potential to experimentally measure arterial NO concentration were discussed, including Raman spectroscopy and electrochemical sensors. In addition to diagnostic methods, therapies aimed at controlling NO delivery to regulate CVD were reviewed, including the NO release platform to treat endothelial dysfunction and atherosclerosis and inhaled NO therapy to treat pulmonary hypertension and COVID-19. Two potential methods to improve the effectiveness of existing NO therapy were also discussed, including the combination of NO release platform and computational modeling, and stem cell therapy, which currently remains at the laboratory stage but has clinical potential for the treatment of CVD.Tianxiang MaZhexi ZhangYu ChenHaoran SuXiaoyan DengXiao LiuYubo FanMDPI AGarticlenitric oxide deliverycomputational modelingflow-mediated dilationNO release platforminhaled NO therapystem cell therapyBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12166, p 12166 (2021)
institution DOAJ
collection DOAJ
language EN
topic nitric oxide delivery
computational modeling
flow-mediated dilation
NO release platform
inhaled NO therapy
stem cell therapy
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle nitric oxide delivery
computational modeling
flow-mediated dilation
NO release platform
inhaled NO therapy
stem cell therapy
Biology (General)
QH301-705.5
Chemistry
QD1-999
Tianxiang Ma
Zhexi Zhang
Yu Chen
Haoran Su
Xiaoyan Deng
Xiao Liu
Yubo Fan
Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy
description Nitric oxide (NO) is a key molecule in cardiovascular homeostasis and its abnormal delivery is highly associated with the occurrence and development of cardiovascular disease (CVD). The assessment and manipulation of NO delivery is crucial to the diagnosis and therapy of CVD, such as endothelial dysfunction, atherosclerotic progression, pulmonary hypertension, and cardiovascular manifestations of coronavirus (COVID-19). However, due to the low concentration and fast reaction characteristics of NO in the cardiovascular system, clinical applications centered on NO delivery are challenging. In this tutorial review, we first summarized the methods to estimate the in vivo NO delivery process, based on computational modeling and flow-mediated dilation, to assess endothelial function and vulnerability of atherosclerotic plaque. Then, emerging bioimaging technologies that have the potential to experimentally measure arterial NO concentration were discussed, including Raman spectroscopy and electrochemical sensors. In addition to diagnostic methods, therapies aimed at controlling NO delivery to regulate CVD were reviewed, including the NO release platform to treat endothelial dysfunction and atherosclerosis and inhaled NO therapy to treat pulmonary hypertension and COVID-19. Two potential methods to improve the effectiveness of existing NO therapy were also discussed, including the combination of NO release platform and computational modeling, and stem cell therapy, which currently remains at the laboratory stage but has clinical potential for the treatment of CVD.
format article
author Tianxiang Ma
Zhexi Zhang
Yu Chen
Haoran Su
Xiaoyan Deng
Xiao Liu
Yubo Fan
author_facet Tianxiang Ma
Zhexi Zhang
Yu Chen
Haoran Su
Xiaoyan Deng
Xiao Liu
Yubo Fan
author_sort Tianxiang Ma
title Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy
title_short Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy
title_full Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy
title_fullStr Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy
title_full_unstemmed Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy
title_sort delivery of nitric oxide in the cardiovascular system: implications for clinical diagnosis and therapy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/d2c6afe4f2734a579c3cb8c8696edcc0
work_keys_str_mv AT tianxiangma deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy
AT zhexizhang deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy
AT yuchen deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy
AT haoransu deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy
AT xiaoyandeng deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy
AT xiaoliu deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy
AT yubofan deliveryofnitricoxideinthecardiovascularsystemimplicationsforclinicaldiagnosisandtherapy
_version_ 1718411889465098240